<![CDATA[Vicore Pharma - Phase two Covid results show 50% lower occur]]>We are long Vicore Pharma. The company is now recruiting for its COVID-19 phase 3 trial is now recruiting in 14 hospitals globally.

Vicore is showing steady progress while continuing to be fairly hidden/unknown and trade at a strong discount in our view, even when considering solely its potential in idiopathic pulmonary fibrosis (IPF).

Link Preview Image
Vicore Pharma – Phase two Covid results show 50% lower occurrence of COVID complications

Vicore Pharma today announced positive results of their Covid drug Phase 2 study. I enclosed below a summary from Pareto Research published today. We are long Vicore Pharma. The company is now recruiting for its COVID-19 phase 3 trial is now recruiting in 14 hospitals globally. Vicore is showing steady progress while continuing to be…

favicon

Fit Investment Ideas (fitinvestmentideas.com)

]]>https://dev.proinvestor.com/forum/topic/443263/vicore-pharma-phase-two-covid-results-show-50-lower-occurRSS for NodeFri, 03 Jul 2026 19:45:16 GMTTue, 02 Nov 2021 13:23:20 GMT60